Literature DB >> 34979039

Imaginal exposure processing during Concurrent Treatment of PTSD and Substance Use Disorders using Prolonged Exposure (COPE) therapy: Examination of linguistic markers of cohesiveness.

Erin M Gandelman1, Steven A Miller1, Sudie E Back2,3.   

Abstract

Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure (COPE) is an integrated, evidence-based treatment that results in significant reductions in posttraumatic stress disorder (PTSD) and substance use disorder (SUD) severity. Emotional processing theory suggests that successful prolonged exposure-based treatments should result in more cohesive trauma narratives due to better integration and organization of trauma memory into cognitive conceptualizations of fear. Therefore, we hypothesized that language used by patients would become more cohesive over time and increased language cohesion would be related to larger reductions in PTSD and SUD outcomes. Broadly, language cohesion refers to several linguistic devices that help establish and cohere meaning throughout spoken and written discourse (e.g., increased use of transition words like "and," "then," and "but"). This was the first known study to examine changes in language related to both PTSD and SUD severity during COPE treatment. The sample included 28 military veterans with current comorbid PTSD/SUD enrolled in a larger COPE study. A text analysis program, Coh-Metrix, was used to analyze language cohesiveness. No language cohesion variables significantly changed over time. Narrativity levels significantly moderated change in PTSD outcomes, R β 2 $R_\beta ^2\;$ = 0.11. Adversative connectives significantly moderated change in SUD outcomes, R β 2 $R_\beta ^2\;$ = 0.26. The findings illuminate potential processes underlying successful COPE treatment. Less use of language conveying a narrative and more use of contrast-indicative words (e.g., but, whereas) was associated with larger reductions in PTSD and SUD outcomes during treatment. These results contribute to the extant literature on associations between trauma exposure, language, and emotional processing.
© 2022 International Society for Traumatic Stress Studies.

Entities:  

Mesh:

Year:  2022        PMID: 34979039      PMCID: PMC9035056          DOI: 10.1002/jts.22786

Source DB:  PubMed          Journal:  J Trauma Stress        ISSN: 0894-9867


  51 in total

1.  Changes in PTSD patients' narratives during prolonged exposure therapy: a replication and extension.

Authors:  Agnes van Minnen; Ineke Wessel; Ton Dijkstra; Karin Roelofs
Journal:  J Trauma Stress       Date:  2002-06

Review 2.  Concurrent Treatment of Substance Use and PTSD.

Authors:  Julianne C Flanagan; Kristina J Korte; Therese K Killeen; Sudie E Back
Journal:  Curr Psychiatry Rep       Date:  2016-08       Impact factor: 5.285

3.  Redefine statistical significance.

Authors:  Daniel J Benjamin; James O Berger; Magnus Johannesson; Brian A Nosek; E-J Wagenmakers; Richard Berk; Kenneth A Bollen; Björn Brembs; Lawrence Brown; Colin Camerer; David Cesarini; Christopher D Chambers; Merlise Clyde; Thomas D Cook; Paul De Boeck; Zoltan Dienes; Anna Dreber; Kenny Easwaran; Charles Efferson; Ernst Fehr; Fiona Fidler; Andy P Field; Malcolm Forster; Edward I George; Richard Gonzalez; Steven Goodman; Edwin Green; Donald P Green; Anthony G Greenwald; Jarrod D Hadfield; Larry V Hedges; Leonhard Held; Teck Hua Ho; Herbert Hoijtink; Daniel J Hruschka; Kosuke Imai; Guido Imbens; John P A Ioannidis; Minjeong Jeon; James Holland Jones; Michael Kirchler; David Laibson; John List; Roderick Little; Arthur Lupia; Edouard Machery; Scott E Maxwell; Michael McCarthy; Don A Moore; Stephen L Morgan; Marcus Munafó; Shinichi Nakagawa; Brendan Nyhan; Timothy H Parker; Luis Pericchi; Marco Perugini; Jeff Rouder; Judith Rousseau; Victoria Savalei; Felix D Schönbrodt; Thomas Sellke; Betsy Sinclair; Dustin Tingley; Trisha Van Zandt; Simine Vazire; Duncan J Watts; Christopher Winship; Robert L Wolpert; Yu Xie; Cristobal Young; Jonathan Zinman; Valen E Johnson
Journal:  Nat Hum Behav       Date:  2018-01

Review 4.  Power failure: why small sample size undermines the reliability of neuroscience.

Authors:  Katherine S Button; John P A Ioannidis; Claire Mokrysz; Brian A Nosek; Jonathan Flint; Emma S J Robinson; Marcus R Munafò
Journal:  Nat Rev Neurosci       Date:  2013-04-10       Impact factor: 34.870

Review 5.  Exclusion of participants based on substance use status: Findings from randomized controlled trials of treatments for PTSD.

Authors:  Robert F Leeman; Kathryn Hefner; Tessa Frohe; Adrian Murray; Robert A Rosenheck; Bradley V Watts; Mehmet Sofuoglu
Journal:  Behav Res Ther       Date:  2016-10-27

Review 6.  The development of a Clinician-Administered PTSD Scale.

Authors:  D D Blake; F W Weathers; L M Nagy; D G Kaloupek; F D Gusman; D S Charney; T M Keane
Journal:  J Trauma Stress       Date:  1995-01

7.  Prevalence and Axis I comorbidity of full and partial posttraumatic stress disorder in the United States: results from Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Robert H Pietrzak; Risë B Goldstein; Steven M Southwick; Bridget F Grant
Journal:  J Anxiety Disord       Date:  2010-11-26

8.  Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders.

Authors:  Denise A Hien; Elizabeth A Wells; Huiping Jiang; Lourdes Suarez-Morales; Aimee N C Campbell; Lisa R Cohen; Gloria M Miele; Therese Killeen; Gregory S Brigham; Yulei Zhang; Cheri Hansen; Candace Hodgkins; Mary Hatch-Maillette; Chanda Brown; Agatha Kulaga; Allison Kristman-Valente; Melissa Chu; Robert Sage; James A Robinson; David Liu; Edward V Nunes
Journal:  J Consult Clin Psychol       Date:  2009-08

9.  Alcoholism treatment of Vietnam veterans with post-traumatic stress disorder.

Authors:  J M Schnitt; J J Nocks
Journal:  J Subst Abuse Treat       Date:  1984

Review 10.  PTSD and comorbid AUD: a review of pharmacological and alternative treatment options.

Authors:  Elizabeth Ralevski; Lening A Olivera-Figueroa; Ismene Petrakis
Journal:  Subst Abuse Rehabil       Date:  2014-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.